Funding

Health Care Startup Thyme Care Raised Over $125M in Series E Funding

Sep 3, 2026 | By Devin Jacobs

SUMMARY

Thyme Care raised over $125M in Series E funding.
The funding will support growth and new care initiatives.
Thyme Care provides technology-enabled cancer care.

Thyme Care, a Nashville, Tenn.-based oncology company, has raised over $125 million in a Series E financing round led by Morgan Health.

The round also saw participation from strategic healthcare investors Humana and CVS Health Ventures, as well as institutional investors AlleyCorp, HealthQuest Capital, Foresite Capital, Concord Health Partners, Frist Cressey Ventures, Town Hall Ventures, and a16z Bio + Health.

The company will use the capital to accelerate growth and build Thyme Companies, a new parent organization focused on addressing challenges across the cancer care journey.

Funding Snapshot

Metric	Details
Fundraise Amount	Over $125 Million
Valuation	Not disclosed
Company	Thyme Care
Sector	HealthTech / Oncology Care
Headquarters	Nashville, Tennessee, US

RECOMMENDED FOR YOU

Startup News

Newmark Appoints Kyle Lutnick as Chief Strategy Officer

Devin Jacobs

May 25, 2026

Funding

[Funding alert] CA-based Sema4.ai Secures $30.5Million in Funding

Devin Jacobs

Jan 30, 2024

[Funding News] LoanBYE Secures $300K from Richard King Mellon Foundation

Team SR

Aug 6, 2024

About Thyme Care

Founded in 2020, Thyme Care provides technology-enabled oncology care designed to align treatment and support around patients. Its services are available to more than 10.5 million people across all 50 US states, while the company manages more than $7 billion in oncology spending.

Core offerings include:

Oncology care management
Patient-centered cancer care
Technology-enabled care coordination
Healthcare cost management

Core Technologies / Products / Services

Capability/Product	Application/Use Case
Oncology Care Management	Supports patients throughout cancer treatment
Care Coordination	Connects patients, providers, and health plans
Data & Technology	Enables coordinated oncology care
Cost Management	Helps reduce total cost of care

Leadership Comments

"People living with cancer have traditionally been left to coordinate care themselves and pay more along the way. Thyme Care is changing that experience and making it possible to improve cancer care while lowering costs," said Dan Mendelson, chief executive officer of Morgan Health.

"When we founded Thyme Care, our vision was never limited to one part of cancer care. We wanted to create a better oncology care system," said Shah. "Thyme Care showed it could be done, and as we've grown alongside patients, providers and health plans, we've gained a deep perspective on the challenges that get in the way of better care.